Received Feb 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 4NG3F | — |
only gave the adjuvant diluent to the patient; only gave the adjuvant diluent to the patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number 4NG3F, expiry date 06-DEC-2025) for prophylaxis. On 28-JAN-2025, the patient received the 1st dose of Shingrix. On 28-JAN-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: only gave the adjuvant diluent to the patient) and inappropriate preparation of medication (Verbatim: only gave the adjuvant diluent to the patient). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown. Additional Information: GSK Receipt Date: 29-JAN-2025 The nurse practitioner explained that a first dose of Shingrix vaccine was administered but they only gave the adjuvant diluent to the patient which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. The vaccine administration facility was the same as primary reporter.